Univest
Univest
  • Markets

Laurus Labs (LAURUSLABS) Share Price Rises 4.02% to Rs 2,306.10 in Today’s Trade

  • September 8, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Laurus Labs Share Price
Laurus Labs Ltd. (LAURUSLABS) share price rose to Rs 2,306.1 today, up 4.02% from the previous close. Market cap was Rs 1,30,755.56 crore.

Laurus Labs Share Price rose to Rs 2,306.10 as of 12:22 PM IST on 17 November 2026, a gain of 4.02% over the previous close of Rs 2,217.05. The price rise adds Rs 89.05 per share and lifts the company’s market capitalisation to Rs 1,30,755.56 crore, according to latest Univest data.

The stock opened at Rs 2,221.00 and has traded between Rs 2,218.00 and Rs 2,307.90 so far, which places Laurus Labs Share Price Today close to the top of its intraday range. Laurus Labs operates in the Pharmaceuticals and Drugs industry within the Healthcare sector.

Table of Contents

Toggle
  • Laurus Labs Share Price Today: Price Action Analysis
  • Why Laurus Labs Ltd. (LAURUSLABS) May Be Moving Today
  • Laurus Labs Ltd. (LAURUSLABS) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching Laurus Labs
  • About Laurus Labs
  • Frequently Asked Questions
    • What is the Laurus Labs share price today?
    • How much has the Laurus Labs share price risen today?
    • What are the day high and day low of Laurus Labs Share Price?
    • What is the market capitalisation of Laurus Labs?
    • What is the P/E ratio of Laurus Labs?
    • What are the ROE and ROCE of Laurus Labs?
    • What are the EPS, book value and dividend yield of Laurus Labs?
    • How does Laurus Labs compare with Sun Pharma and Dr. Reddy's?
  • Track Laurus Labs Share Price on Univest

Laurus Labs Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 2,306.1
Previous Close Rs 2,217.05
Today's Move Rs 89.05 (+4.02%)
Open Rs 2,221
High Rs 2,307.9
Low Rs 2,218
Market Capitalisation Rs 1,30,755.56 crore
Market Cap Category Large Cap

Laurus Labs Ltd. (LAURUSLABS) rose to Rs 2,306.1 from the previous close of Rs 2,217.05, a move of Rs 89.05 or 4.02%. The stock opened at Rs 2,221, reached a high of Rs 2,307.9, recorded a low of Rs 2,218.

Laurus Labs Share Price Today is Rs 2,306.10, up Rs 89.05 or 4.02% from the previous close of Rs 2,217.05. The stock opened at Rs 2,221.00, touched a low of Rs 2,218.00 and reached a high of Rs 2,307.90 as of 12:22 PM IST. That is the Laurus Labs price rise in brief.

The opening level of Rs 2,221.00 was only slightly above the previous close, so most of the gain in Laurus Labs Share Price came after the open. The day low of Rs 2,218.00 also sits above the previous close of Rs 2,217.05, which means the Laurus Labs stock gaining today has traded above yesterday’s reference level throughout the period covered so far.

The latest Laurus Labs Share Price Update therefore shows a stock moving within a range bounded by Rs 2,218.00 and Rs 2,307.90, with a market capitalisation of Rs 1,30,755.56 crore. The reported developments around the company and the fundamental picture behind Laurus Labs Share Price Today follow in the next sections.

Why Laurus Labs Ltd. (LAURUSLABS) May Be Moving Today

According to recent news reports, Laurus Labs’ promoters indicated in a recent interview that they do not intend to sell any further stake in the company, and the report was timed at 12:13 pm IST on 17 November. The reports described the statement as one that may be viewed positively by investors, since it speaks to concerns about any overhang from a possible stake sale. There is one news item in this set, and it may be connected to today’s price rise in Laurus Labs shares. The market data itself does not establish a single confirmed cause for the move, so the item is best read as context reported on the same day rather than a settled explanation.

Laurus Labs Ltd. (LAURUSLABS) Fundamental Analysis

Metric Value
Market Capitalisation Rs 1,30,755.56 crore
P/E Ratio 89.4x
P/B Ratio 19.77x
ROE 18.31%
ROCE 18.2%
EPS Rs 24.8
Book Value Per Share Rs 112.17
Dividend Yield 0.09%

Laurus Labs Ltd. (LAURUSLABS) fundamental metrics show P/E 89.4x, P/B 19.77x, ROE 18.31%, ROCE 18.2%. These ratios show where the company stands today and are not a call to buy or sell.

Laurus Labs Ltd. has a market capitalisation of Rs 1,30,755.56 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 89.4x, P/B at 19.77x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.31% and ROCE of 18.2%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 24.8, book value per share of Rs 112.17, dividend yield of 0.09%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 30.46x, median ROE of 11.33%, median ROCE of 13.1%. Together they describe the fundamental backdrop without implying a buy or sell view.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Pharmaceuticals & Drugs
Benchmark Scope same industry
Company P/E Ratio 89.4x
Benchmark Median P/E 30.46x
Benchmark Average P/E 52.1x
Benchmark P/E Range 2.82x to 1,227.27x
Company P/B Ratio 19.77x
Benchmark Median P/B 2.92x
Company ROE 18.31%
Benchmark Median ROE 11.33%
Company ROCE 18.2%
Benchmark Median ROCE 13.1%
Company Market Capitalisation Rs 1,30,755.56 crore
Benchmark Median Market Cap Rs 760.34 crore

Laurus Labs Ltd. (LAURUSLABS) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Laurus Labs Ltd. (LAURUSLABS) has a P/E ratio of 89.4x, which is above the benchmark median of 30.46x, a difference of +193.5%. A P/E difference of this kind is a reference point rather than a recommendation.

Laurus Labs Ltd. (LAURUSLABS) has a ROE of 18.31%, which is above the benchmark median of 11.33%, a difference of +61.61%. Laurus Labs Ltd. (LAURUSLABS) has a ROCE of 18.2%, which is above the benchmark median of 13.1%, a difference of +38.93%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Sun Pharmaceutical Industries Ltd. SUNPHARMA 4,51,290.91 40.85 5.02 14.85 19.11
Divi's Laboratories Ltd. DIVISLAB 3,05,014.11 87.71 16.39 16.19 21.51
Torrent Pharmaceuticals Ltd. TORNTPHARM 1,77,333.2 83.99 9.71 26.76 19.27
Zydus Lifesciences Ltd. ZYDUSLIFE 1,18,802.71 28.37 4.26 19.69 21.39
Dr. Reddy's Laboratories Ltd. DRREDDY 1,15,016.89 41.17 2.97 11.69 13.75

Laurus Labs Ltd. (LAURUSLABS) has a P/E ratio of 89.4x compared with the displayed peer median of 41.17x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.31% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 18.2% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Laurus Labs Ltd. (LAURUSLABS) has a market capitalisation of Rs 1,30,755.56 crore. Among the 5 peers shown, 3 have a larger market capitalisation.

Why Investors Are Watching Laurus Labs

  • Laurus Labs Share Price rose 4.02% to Rs 2,306.10 against a previous close of Rs 2,217.05.
  • The stock has traded between Rs 2,218.00 and Rs 2,307.90 after opening at Rs 2,221.00.
  • P/E of 89.4 and P/B of 19.77 sit above the industry medians of 30.46 and 2.92.
  • ROE of 18.31% and ROCE of 18.2% are above the industry medians of 11.33% and 13.1%.
  • Market capitalisation of Rs 1,30,755.56 crore is above Zydus Lifesciences and Dr. Reddy’s Laboratories.

About Laurus Labs

Laurus Labs Ltd. carries the stock symbol LAURUSLABS and is classified in the Pharmaceuticals and Drugs industry within the Healthcare sector. According to latest Univest data, the company has a market capitalisation of Rs 1,30,755.56 crore and is benchmarked against 200 companies in the same industry. Its peers in the comparison above include Sun Pharmaceutical Industries, Divi’s Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences and Dr. Reddy’s Laboratories.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

What is the Laurus Labs share price today?

Ans. Laurus Labs Share Price is Rs 2,306.10 as of 12:22 PM IST on 17 November 2026, up Rs 89.05 or 4.02% from the previous close of Rs 2,217.05. Market capitalisation stands at Rs 1,30,755.56 crore.

How much has the Laurus Labs share price risen today?

Ans. The Laurus Labs price rise is 4.02%, or Rs 89.05 per share, compared with the previous close of Rs 2,217.05. The stock opened at Rs 2,221.00 and has touched a high of Rs 2,307.90 so far today.

What are the day high and day low of Laurus Labs Share Price?

Ans. Laurus Labs Share Price has touched a high of Rs 2,307.90 and a low of Rs 2,218.00 today, after opening at Rs 2,221.00. The current price of Rs 2,306.10 sits within that range at present.

What is the market capitalisation of Laurus Labs?

Ans. The Laurus Labs market cap is Rs 1,30,755.56 crore according to latest Univest data. That is above the industry median of Rs 760.34 crore and the industry average of Rs 14,899.39 crore across the 200-company benchmark.

What is the P/E ratio of Laurus Labs?

Ans. Laurus Labs has a P/E ratio of 89.4 and a P/B ratio of 19.77. The industry median P/E is 30.46 and the median P/B is 2.92, so both multiples sit above the benchmark medians in the latest Univest figures.

What are the ROE and ROCE of Laurus Labs?

Ans. Laurus Labs reports ROE of 18.31% and ROCE of 18.2%. The industry medians are 11.33% for ROE and 13.1% for ROCE, so both return ratios are above the benchmark medians in the latest Univest figures.

What are the EPS, book value and dividend yield of Laurus Labs?

Ans. EPS is Rs 24.80, book value per share is Rs 112.17 and dividend yield is 0.09%. EPS shows earnings per share, book value shows net worth per share, and the yield reflects the historical payout against the current price.

How does Laurus Labs compare with Sun Pharma and Dr. Reddy's?

Ans. Laurus Labs P/E of 89.4 is above Sun Pharmaceutical Industries at 40.85 and Dr. Reddy's Laboratories at 41.17. Its ROCE of 18.2% is below Sun Pharmaceutical Industries at 19.11% but above Dr. Reddy's Laboratories at 13.75%.

Track Laurus Labs Share Price on Univest

Use Laurus Labs Ltd. (LAURUSLABS) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Users can track the live Laurus Labs Share Price on Univest, along with fundamental ratios such as P/E, P/B, ROE and ROCE, 52-week levels and wider market insights. The Univest stock page brings Laurus Labs Share Price Today, peer positions and sector benchmarks together in one place, so that changes in the figures discussed above can be followed as the trading day progresses.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply